IMAGE: Lung squamous cell carcinoma

Multimedia

Showing multimedia 31-40 out of 5126.

<  Previous | 2 | 3 | 4 | 5 | 6 | Next  >

Items Per Page: 10 | 30 | 60

Key:    Image    Video    Audio

Spread Stopped

Spread Stopped
All four mouse lungs had been exposed to cancer, but the two on the left were left untreated while the two on the right received an intervention that spurred one particular protein pathway to keep ...

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Heart Failure Survival Rates for Patients With and Without Sarcopenia

Heart Failure Survival Rates for Patients With and Without Sarcopenia
The heart failure survival rate is lower over a 750-day period for patients who have sarcopenia vs those who do not.

Contact: J. Sanderson, N. Fukuda
research-coordinator@jimu.kumamoto-u.ac.jp
Kumamoto University

Brain Natriuretic Peptide (BNP) Levels vs. Patients With and Without Sarcopenia

Brain Natriuretic Peptide (BNP) Levels vs. Patients With and Without Sarcopenia
The risk of heart failure is higher in patients with sarcopenia vs those who don't.

Contact: J. Sanderson, N. Fukuda
research-coordinator@jimu.kumamoto-u.ac.jp
Kumamoto University

Rapalink, A New Generation mTOR Inhibitor

Rapalink, A New Generation mTOR Inhibitor
The Rapalink compound uses a unique strategy to block mTOR, a molecule that helps drive the growth of many tumors.

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute

Colonic Crypt

Colonic Crypt
Balance between the two isoforms, P1 and P2, of nuclear receptor HNF4-alpha in the colonic crypt influences susceptibility to colitis and colon cancer. P1 is seen here in green. P2 is seen in red.

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Immunofluorescent Stained Mouse Intestine

Immunofluorescent Stained Mouse Intestine
Immunofluorescent staining of intestinal epithelium tissue shows cell growth (green). In a normal mouse model (left), cell growth is controlled but in a mouse model with the ERK1/2 pathway blocked (...

Contact: Yadira Galindo
ygalindo@ucsd.edu
619-543-6163
University of California - San Diego

Cancer Cells After Treatment

Cancer Cells After Treatment
After treatment: The breast cancer treatment downregulates FLT3. The cancer cells die.

Contact: Iris Uras
iris.uras@vetmeduni.ac.at
43-699-182-04603
University of Veterinary Medicine -- Vienna

Cancer Cells Before Treatment

Cancer Cells Before Treatment
This is a photograph of cancer cells before treatment.

Contact: Iris Uras
iris.uras@vetmeduni.ac.at
43-699-182-04603
University of Veterinary Medicine -- Vienna

Leukemia Therapy

Leukemia Therapy
Childhood cancer: targeted therapy of resistant leukemia cells.

Contact: Beat Bornhauser
beat.bornhauser@kispi.uzh.ch
41-446-348-817
University of Zurich

DNA Damage in Mouse Ovary Treated with Cisplatin

DNA Damage in Mouse Ovary Treated with Cisplatin
A section of mouse ovary treated with cisplatin (chemotherapy drug) for 24 hours. Red staining labels oocytes, green staining marks DNA damage and blue shows nuclei of all cells.

Contact: Joyce Peterson
joyce.peterson@jax.org
207-288-6058
Jackson Laboratory

Showing multimedia 31-40 out of 5126.

<  Previous | 2 | 3 | 4 | 5 | 6 | Next  >

Items Per Page: 10 | 30 | 60

  Search News Releases

     

 

EurekAlert!